COVID-19-associated Coagulopathy Characterization using Rotational Thromboelastometry in a Prospective, Observational Cohort Study: The HemoCoV Study
Authors:
- Anabela RodriguesAnabela Rodrigues
- Tiago Dias DominguesTDTiago Dias Domingues
- Gustavo Nobre JesusGJGustavo Nobre Jesus
- Ana GarçãoAGAna Garção
- Ana Rita RodriguesARAna Rita Rodrigues
- Catarina Jacinto CorreiaCCCatarina Jacinto Correia
- Carla Leal PereiraCPCarla Leal Pereira
- Dulce CorreiaDCDulce Correia
- Álvaro BelezaÁBÁlvaro Beleza
- João Miguel RibeiroJRJoão Miguel Ribeiro
Open Access
- 3 July 2023
- journal article
- research article
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 36 (7-8) , 496-505
Abstract
Introduction: COVID-19-associated coagulopathy includes systemic and endothelial inflammation with coagulation dysregulation related to immunothrombosis. The aim of this study was to characterize this complication of SARS-CoV-2 infection in patients with moderate to severe COVID-19. Methods: An open-label, prospective observational study conducted in patients with COVID-19 moderate to severe acute respiratory failure admitted to an intensive care unit (ICU). Coagulation testing, including thromboelastometry, biochemical analysis and clinical variables, were collected at prespecified time points during the 30 days of ICU stay.Results: The study included 145 patients, 73.8% male, with a median age of 68 years (interquartile range - IQR 55 - 74). The most prevalent comorbidities were arterial hypertension (63.4%), obesity (44.1%) and diabetes (22.1%). Simplified acute physiology score II (SAPS II) was on average 43.5 (11 - 105) and sequential organ failure assessment (SOFA) at admission was 7.5 (0 - 14). During ICU stay, 66.9% of patients underwent invasive mechanical ventilation and 18.4% extracorporeal membrane oxygenation support; thrombotic and hemorrhagic events occurred in 22.1% and 15.1% of the patients respectively; anticoagulation with heparin was present in 99.2% of patients since early ICU stay. Death occurred in 35% of patients. Longitudinal studies revealed changes in almost all coagulation tests during the ICU stay. SOFA score, lymphocyte counts, some biochemical, inflammatory and coagulation parameters, including hypercoagulability and hypofibrinolysis seen in thromboelastometry, differed significantly (p < 0.05), between ICU admission and discharge. Hypercoagulability and hypofibrinolysis persisted throughout ICU hospitalization, showing higher incidence and severity in non-survivors.Conclusion: COVID-19-associated coagulopathy is characterized by hypercoagulability and hypofibrinolysis from ICU admission, and persisted throughout the clinical course in severe COVID-19. These changes were more pronounced in patients with higher disease burden and in non-survivors.Keywords
This publication has 38 references indexed in Scilit:
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, ChinaJAMA Internal Medicine, 2020
- Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysisClinical Chemistry and Laboratory Medicine (CCLM), 2020
- Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19Journal of Medical Virology, 2020
- Prominent changes in blood coagulation of patients with SARS-CoV-2 infectionClinical Chemistry and Laboratory Medicine (CCLM), 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding managementKorean Journal of Anesthesiology, 2019
- Guidelines for the use of platelet transfusionsBritish Journal of Haematology, 2016
- Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reportingBMJ Open, 2011
- Glomerular filtration rate measurement and estimation in chronic kidney diseasePediatric Nephrology, 2007